Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.68 -0.71 (-2.59%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) EBITDA (2013 - 2026)

Updated

Amphastar Pharmaceuticals' EBITDA came in at $54.04 million for Q2 2026, down 4.9% from $56.8 million a year earlier but up 93.2% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) EBITDA (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Amphastar Pharmaceuticals reported EBITDA of $171.41 million, down 28.4% year-over-year; for FY2025, it was $197.1 million, down 23.7% from FY2024.

  • EBITDA carries a five-year compound annual growth rate of 56.5% (FY2020 to FY2025).
  • Going back by year, EBITDA was $258.39 million in FY2024 (+9.7%), $235.55 million in FY2023 (+94.6%), $121.05 million in FY2022 (+49.1%) and $81.18 million in FY2021 (+286.2%).
  • The five-year range for quarterly EBITDA is $24.71 million (Q1 2022) to $88.48 million (Q3 2023).
  • Year-over-year, EBITDA has declined for eight consecutive quarters, with an average decline of 23.1% over the last eight quarters.
  • The fastest year-over-year change in EBITDA over five years came in Q4 2021 (growth of 378.2%), and the weakest in Q3 2025 (a decline of 46.0%).
  • Business Quant data shows AMPH's EBITDA at $27.98 million (Q1 2026), $49.95 million (Q4 2025) and $39.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.10 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 8.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 5.09 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.30 Bn
10 Amphastar Pharmaceuticals 1.16 Bn 23.86 Mn 93.47 Mn 54.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.04 Mn
Mar 31, 2026 27.98 Mn
Dec 31, 2025 49.95 Mn
Sep 30, 2025 39.45 Mn
Jun 30, 2025 56.80 Mn
Mar 31, 2025 50.90 Mn
Dec 31, 2024 58.58 Mn
Sep 30, 2024 73.02 Mn
Jun 30, 2024 71.09 Mn
Mar 31, 2024 63.84 Mn
Dec 31, 2023 69.82 Mn
Sep 30, 2023 88.48 Mn
Jun 30, 2023 40.19 Mn
Mar 31, 2023 37.07 Mn
Dec 31, 2022 41.49 Mn
Sep 30, 2022 26.88 Mn
Jun 30, 2022 27.97 Mn
Mar 31, 2022 24.71 Mn
Dec 31, 2021 26.99 Mn
Sep 30, 2021 27.65 Mn
API Access

Amphastar Pharmaceuticals EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=AMPH&period=max&api_key=YOUR_API_KEY